Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

copper Cu 62 ethylglyoxal bis(thiosemicarbazone)

A radiopharmaceutical composed of the nonspecific perfusion agent ethylglyoxal bis(thiosemicarbazone) (ETS) linked to the beta-emitting, radioisotope copper Cu 62, with potential tumor imaging activity upon positron emitting tomography (PET). Upon injection, copper Cu 62-ETS distributes to various organs, especially the kidneys and the myocardium. Upon PET imaging, tumor blood flow can be visualized and the efficacy of antineoplastic and anti-angiogenic chemotherapeutics can be assessed. Cu62-ETS has a short half life of 9.74 minutes. ETS has an enhanced hyperemic response compared to other perfusion agents.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:62Cu-ethylglyoxal bis
62Cu-ethylglyoxal bis(thiosemicarbazone)
Abbreviation:62Cu-ETS
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search